BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26927669)

  • 41. Issue Highlights-May 2018 (94B3).
    Wallace PK
    Cytometry B Clin Cytom; 2018 May; 94(3):387-391. PubMed ID: 29734502
    [No Abstract]   [Full Text] [Related]  

  • 42. Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL/6-CD45.1(STEM) Mouse.
    Mercier FE; Sykes DB; Scadden DT
    Stem Cell Reports; 2016 Jun; 6(6):985-992. PubMed ID: 27185283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct bone marrow blood vessels differentially regulate haematopoiesis.
    Itkin T; Gur-Cohen S; Spencer JA; Schajnovitz A; Ramasamy SK; Kusumbe AP; Ledergor G; Jung Y; Milo I; Poulos MG; Kalinkovich A; Ludin A; Kollet O; Shakhar G; Butler JM; Rafii S; Adams RH; Scadden DT; Lin CP; Lapidot T
    Nature; 2016 Apr; 532(7599):323-8. PubMed ID: 27074509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.
    Tang CH; Zundell JA; Ranatunga S; Lin C; Nefedova Y; Del Valle JR; Hu CC
    Cancer Res; 2016 Apr; 76(8):2137-52. PubMed ID: 26951929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
    Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
    J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma.
    Binder M; Rajkumar SV; Ketterling RP; Dispenzieri A; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Hwa YL; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kyle RA; Kumar SK
    Blood Cancer J; 2016 Mar; 6(3):e401. PubMed ID: 26967818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma.
    Baz RC; Martin TG; Lin HY; Zhao X; Shain KH; Cho HJ; Wolf JL; Mahindra A; Chari A; Sullivan DM; Nardelli LA; Lau K; Alsina M; Jagannath S
    Blood; 2016 May; 127(21):2561-8. PubMed ID: 26932802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.
    Kumar A; Coleman I; Morrissey C; Zhang X; True LD; Gulati R; Etzioni R; Bolouri H; Montgomery B; White T; Lucas JM; Brown LG; Dumpit RF; DeSarkar N; Higano C; Yu EY; Coleman R; Schultz N; Fang M; Lange PH; Shendure J; Vessella RL; Nelson PS
    Nat Med; 2016 Apr; 22(4):369-78. PubMed ID: 26928463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.
    Sykes DB; Kfoury YS; Mercier FE; Wawer MJ; Law JM; Haynes MK; Lewis TA; Schajnovitz A; Jain E; Lee D; Meyer H; Pierce KA; Tolliday NJ; Waller A; Ferrara SJ; Eheim AL; Stoeckigt D; Maxcy KL; Cobert JM; Bachand J; Szekely BA; Mukherjee S; Sklar LA; Kotz JD; Clish CB; Sadreyev RI; Clemons PA; Janzer A; Schreiber SL; Scadden DT
    Cell; 2016 Sep; 167(1):171-186.e15. PubMed ID: 27641501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of the bone marrow niche.
    Yu VW; Scadden DT
    Curr Opin Hematol; 2016 Jul; 23(4):331-8. PubMed ID: 27177311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel hematopoietic progenitor cell mobilization regimen, utilizing bortezomib and filgrastim, for patients undergoing autologous transplant.
    Abhyankar S; Lubanski P; DeJarnette S; Merkel D; Bunch J; Daniels K; Aljitawi O; Lin T; Ganguly S; McGuirk J
    J Clin Apher; 2016 Dec; 31(6):559-563. PubMed ID: 26939585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment.
    Pisklakova A; Grigson E; Ozerova M; Chen F; Sullivan DM; Nefedova Y
    Cancer Biol Ther; 2016 May; 17(5):477-85. PubMed ID: 26934342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of ARMH4 and WIPF3 as human podocyte proteins with potential roles in immunomodulation and cytoskeletal dynamics.
    De Luca F; Kha M; Swärd K; Johansson ME
    PLoS One; 2023; 18(1):e0280270. PubMed ID: 36649229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In situ cell-type-specific cell-surface proteomic profiling in mice.
    Shuster SA; Li J; Chon U; Sinantha-Hu MC; Luginbuhl DJ; Udeshi ND; Carey DK; Takeo YH; Xie Q; Xu C; Mani DR; Han S; Ting AY; Carr SA; Luo L
    Neuron; 2022 Dec; 110(23):3882-3896.e9. PubMed ID: 36220098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptomic Biomarker Signatures for Discrimination of Oral Cancer Surgical Margins.
    Fox SA; Vacher M; Farah CS
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Huang H; Zhu L; Huang C; Dong Y; Fan L; Tao L; Peng Z; Xiang R
    Front Oncol; 2021; 11():726655. PubMed ID: 34660292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Armadillo-like helical domain containing-4 is dynamically expressed in both the first and second heart fields.
    Conway SJ; McConnell R; Simmons O; Snider PL
    Gene Expr Patterns; 2019 Dec; 34():119077. PubMed ID: 31655130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.
    Towner RA; Smith N; Saunders D; Brown CA; Cai X; Ziegler J; Mallory S; Dozmorov MG; Coutinho De Souza P; Wiley G; Kim K; Kang S; Kong DS; Kim YT; Fung KM; Wren JD; Battiste J
    Transl Oncol; 2019 Feb; 12(2):320-335. PubMed ID: 30468988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma.
    Poole CJ; Zheng W; Lodh A; Yevtodiyenko A; Liefwalker D; Li H; Felsher DW; van Riggelen J
    Oncotarget; 2017 Sep; 8(44):76898-76920. PubMed ID: 29100357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.
    Camacho V; McClearn V; Patel S; Welner RS
    Int J Hematol; 2017 May; 105(5):566-577. PubMed ID: 28176225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.